© 1993 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology
Department of Clinical Pharmacology, University of Groningen, Bloemsingel 1, 9713 BZ Groningen, The Netherlands: Y M Pinto, B G J L de Smet, W H van Gilst, E Scholtens, S Monnink, P A de Graeff, H Wesseling.
Correspondence to Dr Pinto.
Objective: The cardiac renin-angiotensin system is activated in experimental heart failure, but it is unknown at what stage of heart failure it becomes activated, and whether activation is related to ventricular dysfunction and dilatation. Changes in activity of cardiac, renal, and plasma angiotensin converting enzyme (ACE) were therefore examined at different stages of experimental heart failure, with simultaneous measurements of left ventricular pressure, systolic dP/dt, and inner ventricular radius. Methods: Heart failure was induced by experimental infarction in 17 normotensive male Wistar rats; 14 rats were sham operated. Rats were killed 3, 5, or 80 d after infarction. In an isolated heart perfusion, left ventricular pressure and systolic dP/dT were measured. ACE activity was determined in samples of the left and right cardiac ventricle, kidney, and plasma. Radius of the ventricular cavity was planimetrically determined in transverse sections of the left ventricle. Results: At the different stages both left ventricular pressure and systolic dP/dT progressively decreased and inner radius of the left ventricle increased in all heart failure groups. ACE activity in the left ventricle increased significantly in all heart failure groups and correlated inversely with left ventricular pressure (R=–0.81; p < 0.001) and dP/dt (R=–0.85; p < 0.001). ACE activity in the kidney was only increased 80 d after the induction of heart failure [17(SEM 1) v 11.2(0.5) nM His-Leu generated per min·mg–1, p < 0.01], while plasma ACE activity was not increased in any heart failure group. Conclusions: Cardiac ACE is activated in the early stage after induction of heart failure and is related to the amount of dysfunction. ACE in the kidney is activated only in the chronic stage. The cardiac renin-angiotensin system therefore already appears to be an important neurohumoral adjustment in the early stage of heart failure and is thereby a suitable target for early intervention by ACE inhibitors.
Cardiovascular Research 1993;27:1933-1938
KEYWORDS angiotensin converting enzyme; experimental heart failure; ventricular remodelling; sympathetic sensitivity; cardiac function
The authors would like to express their gratitude to Hans Bartels for biotechnical assistance, and to Katja Wolters for biochemical analysis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Messaoudi, P. Milliez, J.-L. Samuel, and C. Delcayre Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density FASEB J, July 1, 2009; 23(7): 2176 - 2185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Grobe, A. P. Mecca, H. Mao, and M. J. Katovich Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2417 - H2423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Westendorp, R. G. Schoemaker, H. Buikema, F. Boomsma, D. J. van Veldhuisen, and W. H. van Gilst Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction Eur J Heart Fail, March 1, 2006; 8(2): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Westendorp, R. G. Schoemaker, H. Buikema, D. de Zeeuw, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril Eur J Heart Fail, December 1, 2005; 7(7): 1085 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A van der Wouden, R. H Henning, L. E Deelman, A. J. Roks, F. Boomsma, and D. de Zeeuw Does Angiotensin (1-7) Contribute to the Antiproteinuric Effect of ACE-inhibitors? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2005; 6(2): 96 - 101. [Abstract] [PDF]
|
|
|
|
 |
|
 L. S. Zisman Myocardial infarction increases ACE2 expression in rat and humans: reply Eur. Heart J., June 1, 2005; 26(11): 1141 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
B. Westendorp, R. G Schoemaker, H. Buikema, D. de Zeeuw, D. J van Veldhuisen, and W. H van Gilst Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 27 - 32. [Abstract] [PDF]
|
|
|
|
|
|
S. Gschwend, H. Buikema, R. H. Henning, Y. M. Pinto, D. de Zeeuw, and W. H. van Gilst Endothelial dysfunction and infarct-size relate to impaired EDHF response in rat experimental chronic heart failure Eur J Heart Fail, March 1, 2003; 5(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. de Boer, Y. M. Pinto, A. J.H. Suurmeijer, S. Pokharel, E. Scholtens, M. Humler, J. M. Saavedra, F. Boomsma, W. H. van Gilst, and D. J. van Veldhuisen Increased expression of cardiac angiotensin II type 1 (AT1) receptors decreases myocardial microvessel density after experimental myocardial infarction Cardiovasc Res, February 1, 2003; 57(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J Wagenaar, H. Buikema, Y. M Pinto, and W. H van Gilst Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade? Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S64 - S69. [Abstract] [PDF]
|
|
|
|
|
|
P. S. Tappia, S.-Y. Liu, S. Shatadal, N. Takeda, N. S. Dhalla, and V. Panagia Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H40 - H49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, B. S. Huang, and F. H. H. Leenen Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1608 - H1615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Liu and I. H. Zucker Regulation of Sympathetic Nerve Activity in Heart Failure : A Role for Nitric Oxide and Angiotensin II Circ. Res., March 5, 1999; 84(4): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. H. Leenen, V. Skarda, B. Yuan, and R. White Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H317 - H325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]
|
|
|
|
 |
|
 A. Luchner, T. L. Stevens, D. D. Borgeson, M. M. Redfield, J. E. Bailey, S. M. Sandberg, D. M. Heublein, and J. C. Burnett Angiotensin II in the Evolution of Experimental Heart Failure Hypertension, September 1, 1996; 28(3): 472 - 477. [Abstract] [Full Text]
|
|
|
|
|
|
F. Pieruzzi, Z. A. Abassi, and H. R. Keiser Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure Circulation, November 15, 1995; 92(10): 3105 - 3112. [Abstract] [Full Text]
|
|